320 SOQUEL WAY, SUNNYVALE, CA
Reg. FD
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Announces $4.4 Million Financing
FDA Confirms HF II May Support Premarket Approval of Cell Therapy for Ischemic HFrEF
Announces Japan PMDA Record of Advice Supports Regulatory Submission for Approval of Cell Therapy for Ischemic Heart Failure
Announces Chronic Myocardial Ischemia Trial Results Presented at EuroPCR Showed Durable Improvements in Exercise Tolerance with Reduced Angina Frequency
Reports First Quarter 2026 Business Highlights and Financial Results
FDA Align on Helix Transendocardial Delivery Catheter Clearance Pathways
Q1
FY 2025
Q3
Amended Quarterly Report
Q2
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Prospectus filed pursuant to Rule 424(b)(4)
Effectiveness Notice
Amended Registration Statement for Securities
S-1
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload